Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct;54(10):2436-47.
doi: 10.1128/JCM.00211-16. Epub 2016 May 4.

Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting

Affiliations
Review

Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting

Matthew L Faron et al. J Clin Microbiol. 2016 Oct.

Abstract

Infections attributable to vancomycin-resistant Enterococcus (VRE) strains have become increasingly prevalent over the past decade. Prompt identification of colonized patients combined with effective multifaceted infection control practices can reduce the transmission of VRE and aid in the prevention of hospital-acquired infections (HAIs). Increasingly, the clinical microbiology laboratory is being asked to support infection control efforts through the early identification of potential patient or environmental reservoirs. This review discusses the factors that contribute to the rise of VRE as an important health care-associated pathogen, the utility of laboratory screening and various infection control strategies, and the available laboratory methods to identify VRE in clinical specimens.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Vancomycin acts by binding to d-Ala-d-Ala pentapeptides blocking cell wall biosynthesis. Resistance to vancomycin is conferred by the van operon, which consists of a two-component regulatory system (vanS-vanR) that responds to either vancomycin, disruption at the cell membrane, or both. Detection of stimulus then activates downstream genes vanH, vanA or vanB and vanX. VanX is a d,d-dipeptidase that cleaves d-Ala-d-Ala repeats, both depleting the pool of d-Ala-d-Ala and supplying the bacteria with a free d-Ala for Van(A/B). VanH is a d-hydroxyacid dehydrogenase that reduces pyruvate to d-Lac for the ligase Van(A/B). Van(A/B) then ligates d-Ala-d-Lac, allowing for the production of d-Ala-d-Lac pentapeptides that have low affinity for vancomycin. In addition, VanY is a d,d-carboxypeptidase that cleaves the d-Ala terminal peptide to further reduce pools of pentapeptides that have high affinity to vancomycin. Finally, VanZ, which is present on vanA-carrying strains, confers modest resistance to teicoplanin through an unknown mechanism. Differences in the level of resistance are likely a result of pentapeptide composition, as the ratio between pentapeptides consisting of high affinity to low affinity to vancomycin correlate with the isolate MICs. High-level resistance (HLR) occurs when pentapeptides are mostly composed of low-affinity molecules, and moderate-level resistance (MLR) involves more-heterogeneous pools of high- and low-affinity pentapeptides.
None

References

    1. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Witte W, Friedrich AW. 2014. Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill 19:pii=20860. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20860. - PubMed
    1. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN) Team and Participating NHSN Families. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 34:1–14. doi:10.1086/668770. - DOI - PubMed
    1. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. 2007. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28:196–203. - PubMed
    1. Wang JS, Muzevich K, Edmond MB, Bearman G, Stevens MP. 2014. Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature. Int J Infect Dis 25:26–31. doi:10.1016/j.ijid.2014.01.009. - DOI - PubMed
    1. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. 2005. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41:327–333. doi:10.1086/430909. - DOI - PubMed

MeSH terms

LinkOut - more resources